[Cellomics Technology] CMV-Firefly luciferase lentivirus (Neo)
PLV-10064-50
|
CMV-Firefly luciferase lentivirus (Neo) (2x25ul)
|
Titer 1x10^8 TU/ml |
PLV-10064-200
|
CMV-Firefly luciferase lentivirus (Neo) (8x25ul)
|
Titer 1x10^8 TU/ml |
Luciferase is an enzyme that is catalyzes the oxidation of luciferin to generate bioluminescence. Firefly luciferase refers to the enzyme that was isolated from Photinus pyralis. This lentivirus expresses Firefly luciferase under the control of CMV promoter.
Virus: | CMV-Firefly luciferase (Neo) |
Titer (approx): | 1 x 108 CFU/ml |
Vector Information: | Vector includes both 5’ and 3’ lentiviral LTR and all necessary elements for effective transduction; woodchuck hepatitis virus posttranscriptional regulatory element (WPRE) |
Promoter for Target Gene: | CMV |
Target Gene / Reporter(s): | Firefly luciferase |
Selection Gene: | Neomycin |
Biosafety Level: | BSL-2 |
Shipped: | Dry ice |
Storage: | Store at -80°C |
'Cellomics Technology' 카테고리의 다른 글
[Cellomics Technology] ViroGold Lenti Concentrator (VG-1001-1000ml) (0) | 2025.05.28 |
---|---|
[Cellomics Technology] Lentiviral vector-CAG, Hyg (0) | 2025.05.22 |
[Cellomics Technology] Lentiviral vector-CAG, Neo (0) | 2025.04.23 |
[Cellomics Technology] Lentiviral vector-CMV, Hyg-2A-GFP (0) | 2025.04.07 |
[Cellomics Technology] Lentiviral BAP1 sgRNA CRISPR/Cas9 (0) | 2025.04.02 |